Pancreatic cancer: a review of current treatment and novel therapies
HM Kolbeinsson, S Chandana, GP Wright… - Journal of Investigative …, 2023 - Taylor & Francis
… In summary, pancreatic cancer remains a disease with poor long-… pancreatic cancer
treatment and the milestones that brought us to where we are today, along with emerging therapies…
treatment and the milestones that brought us to where we are today, along with emerging therapies…
Pasireotide: a novel treatment for tumor-induced hypoglycemia due to insulinoma and non-islet cell tumor hypoglycemia
M Siddiqui, A Vora, S Ali, J Abramowitz… - … of the Endocrine …, 2021 - academic.oup.com
… the pancreatic head, suspicious for a small insulinoma, but endoscopic ultrasound failed to
localize the tumor… any abnormal uptake concerning for neuroendocrine tumor, and a selective …
localize the tumor… any abnormal uptake concerning for neuroendocrine tumor, and a selective …
Cancer-associated fibroblasts: mechanisms of tumor progression and novel therapeutic targets
RP Czekay, DJ Cheon, R Samarakoon, SM Kutz… - Cancers, 2022 - mdpi.com
… tumor survival [79]. Clarifying the impact of the dynamic CAF environment on tumor growth
and metastasis may inform novel treatment strategies targeting specific CAF populations. …
and metastasis may inform novel treatment strategies targeting specific CAF populations. …
Novel therapeutic strategies for CDK4/6 inhibitors in metastatic castrate-resistant prostate cancer
AM Kase, JA Copland III, W Tan - OncoTargets and therapy, 2020 - Taylor & Francis
… combinatorial therapies with CDK4/6i’s. Table 1 shows mutated genes in mCRPC and
will be referred throughout this review in guiding novel combinatorial therapeutic strategies. …
will be referred throughout this review in guiding novel combinatorial therapeutic strategies. …
Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer
SR Pierce, Z Fang, Y Yin, L West, M Asher… - … & Clinical Cancer …, 2021 - Springer
… cancer. These studies support DRD2 antagonism via ONC201 as a promising therapeutic
strategy for endometrial cancer … in both serous and endometrioid endometrial cancer patients. …
strategy for endometrial cancer … in both serous and endometrioid endometrial cancer patients. …
A precision medicine drug discovery pipeline identifies combined CDK2 and 9 inhibition as a novel therapeutic strategy in colorectal cancer
JA Somarelli, RS Roghani, AS Moghaddam… - … cancer therapeutics, 2020 - AACR
… is a useful platform to identify novel inhibitors. This platform led to the identification of dual
CDK2/9 inhibition as a promising therapeutic strategy to treat metastatic colorectal cancer. …
CDK2/9 inhibition as a promising therapeutic strategy to treat metastatic colorectal cancer. …
Targeted cancer therapy: what's new in the field of neuroendocrine neoplasms?
A La Salvia, P Espinosa-Olarte, MDC Riesco-Martinez… - Cancers, 2021 - mdpi.com
… Despite recent therapeutic achievements, thus, systemic treatment options remain … therapies
in the field of NETs, and also future perspectives of novel therapeutic drugs or strategies in …
in the field of NETs, and also future perspectives of novel therapeutic drugs or strategies in …
Targeting PRAS40: a novel therapeutic strategy for human diseases
Q Zhou, S Tang, X Zhang, L Chen - Journal of Drug Targeting, 2021 - Taylor & Francis
… more and more attention, especially in the process of cancer. With its further studies, we
believe that PRAS40 can be used as a novel target for disease treatment and drug research. …
believe that PRAS40 can be used as a novel target for disease treatment and drug research. …
Homogeneous MMR deficiency throughout the entire tumor mass occurs in a subset of colorectal neuroendocrine carcinomas
C Fraune, R Simon, C Hube-Magg… - Endocrine …, 2020 - Springer
… , demanding novel treatment strategies such as immune checkpoint inhibition in tumors with
… of 10) but highly infrequent in neuroendocrine neoplasms from many other sites. The lack of …
… of 10) but highly infrequent in neuroendocrine neoplasms from many other sites. The lack of …
The role of DLLs in cancer: a novel therapeutic target
MX Xiu, YM Liu, B Kuang - OncoTargets and therapy, 2020 - Taylor & Francis
… vasculature and tumor immunity, which play different roles in cancer progression. DLLs … as
anti-cancer therapeutics. In this review, we discuss the role of DLLs in cancer and summarize …
anti-cancer therapeutics. In this review, we discuss the role of DLLs in cancer and summarize …